We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
Cap. Flow
+$859M
Cap. Flow %
5.88%
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.3M
2
AMGN icon
Amgen
AMGN
+$88.7M
3
ALL icon
Allstate
ALL
+$52.2M
4
UNP icon
Union Pacific
UNP
+$47.1M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$44.7M

Sector Composition

Rank Sector Weight
1 Healthcare 33.42%
2 Technology 23.2%
3 Consumer Discretionary 9.14%
4 Financials 8.63%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAL icon
501
TAL Education Group
TAL
$5.86B
$2.96M 0.02%
117,335
-83,477
-42% -$3.73M
SONY icon
502
Sony
SONY
$131B
$2.95M 0.02%
151,700
+27,420
+22% +$556K
DOV icon
503
Dover
DOV
$27.7B
$2.95M 0.02%
19,565
+950
+5% +$140K
SPY icon
504
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$2.95M 0.02%
632,400
+41,600
+7% +$17.4M
FAST icon
505
Fastenal
FAST
$54.7B
$2.94M 0.02%
113,182
-245,888
-68% -$6.4M
AIG icon
506
American International
AIG
$42B
$2.94M 0.02%
61,788
-86,306
-58% -$4.27M
SHOP icon
507
Shopify
SHOP
$165B
$2.93M 0.02%
20,030
+6,010
+43% +$741K
EOG icon
508
EOG Resources
EOG
$74.7B
$2.9M 0.02%
34,735
+2,963
+9% +$234K
KKR icon
509
KKR & Co
KKR
$91.3B
$2.89M 0.02%
+48,774
New +$2.71M
CIT
510
DELISTED
CIT Group Inc.
CIT
$2.89M 0.02%
+55,952
New +$2.94M
APH icon
511
Amphenol
APH
$184B
$2.83M 0.02%
82,738
+39,380
+91% +$1.33M
FCX icon
512
Freeport-McMoran
FCX
$90.2B
$2.82M 0.02%
75,873
-88,787
-54% -$3.46M
MRVL icon
513
Marvell Technology
MRVL
$170B
$2.79M 0.02%
47,862
-18,400
-28% -$899K
CTAS icon
514
Cintas
CTAS
$84.4B
$2.78M 0.02%
29,148
+1,620
+6% +$144K
FTS icon
515
Fortis
FTS
$29.7B
0
CHD icon
516
Church & Dwight Co
CHD
$23.4B
$2.76M 0.02%
32,393
-137,795
-81% -$11.9M
CARR icon
517
Carrier Global
CARR
$57.6B
$2.76M 0.02%
56,785
+2,380
+4% +$106K
SEM
518
DELISTED
Select Medical
SEM
$2.76M 0.02%
+121,022
New +$2.51M
GMED icon
519
Globus Medical
GMED
$10.6B
$2.71M 0.02%
+35,000
New +$2.49M
KHC icon
520
Kraft Heinz
KHC
$31.1B
$2.68M 0.02%
65,659
+12,555
+24% +$528K
HDB icon
521
HDFC Bank
HDB
$119B
$2.67M 0.02%
73,000
-436,030
-86% -$16M
FOE
522
DELISTED
Ferro Corporation
FOE
$2.67M 0.02%
+123,663
New +$2.43M
ROKU icon
523
Roku
ROKU
$21.2B
$2.66M 0.02%
5,795
+337
+6% +$119K
SYY icon
524
Sysco
SYY
$40.2B
$2.65M 0.02%
34,144
-2,439
-7% -$197K
AVB icon
525
AvalonBay Communities
AVB
$26.8B
$2.64M 0.02%
12,654
-840
-6% -$168K

Similar funds

Candriam SCA's Q2 2021 Portfolio in Review

As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.

  • Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
  • Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
  • Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
  • Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
  • Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
  • Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.

Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.